SEC Form 4 · accession 0000921895-16-005617
Actinium Pharmaceuticals, Inc. · ATNM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Aug 30, 2016
Accepted (ET)
Sep 1, 2016 · 5:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 30, 2016 | S | 23,500 | $1.80 | D | 4,878,988 | D | |
| Common Stock | Aug 30, 2016 | S | 1,500 | $1.805 | D | 4,877,488 | D | |
| Common Stock | Aug 30, 2016 | S | 30,474 | $1.81 | D | 4,847,014 | D | |
| Common Stock | Aug 30, 2016 | S | 200 | $1.8125 | D | 4,846,814 | D | |
| Common Stock | Aug 30, 2016 | S | 300 | $1.815 | D | 4,846,514 | D | |
| Common Stock | Aug 30, 2016 | S | 100 | $1.82 | D | 4,846,414 | D | |
| Common Stock | Aug 31, 2016 | S | 25,188 | $1.80 | D | 4,821,226 | D | |
| Common Stock | Aug 31, 2016 | S | 6,400 | $1.81 | D | 4,814,826 | D | |
| Common Stock | Aug 31, 2016 | S | 200 | $1.815 | D | 4,814,626 | D | |
| Common Stock | Aug 31, 2016 | S | 25,100 | $1.82 | D | 4,789,526 | D | |
| Common Stock | Aug 31, 2016 | S | 800 | $1.83 | D | 4,788,726 | D | |
| Common Stock | Aug 31, 2016 | S | 15,000 | $1.84 | D | 4,773,726 | D | |
| Common Stock | Aug 31, 2016 | S | 40,200 | $1.85 | D | 4,733,526 | D | |
| Common Stock | Aug 31, 2016 | S | 9,800 | $1.86 | D | 4,723,726 | D | |
| Common Stock | Aug 31, 2016 | S | 14,165 | $1.87 | D | 4,709,561 | D |
Table II — derivative securities
No Table II lines on this filing.